Top Markets
Coin of the day
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Kedudukan dalam Saham #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Harga Saham
$0.7426
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$69.05M
Perubahan (1 hari)
-2.17%
Perubahan (1 tahun)
-57.57%
Negara
US
Perdagangan Citius Oncology, Inc. (CTOR)

Kategori

Sejarah pecahan saham untuk Citius Oncology, Inc. (CTOR)
Saham Citius Oncology, Inc. (simbol: CTOR) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 22, 2026.
Satu saham CTOR yang dibeli sebelum Aug 22, 2026 kini bersamaan dengan 0 saham CTOR.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
4 x15
US
7 x432
US
0 -
US
2 x10000
CH
7 x226
US